regulation of pd-l1 in cutaneous lymphoma by mirnas
Published 5 years ago • 81 plays • Length 3:00Download video MP4
Download video MP3
Similar videos
-
1:14
pd-l1 inhibitors in r/r hodgkin lymphoma
-
2:04
imc-001: preliminary results of novel pd-l1 inhibitor for r/r extranodal nk/t cell lymphoma
-
2:32
the growing role of anti-pd1 inhibitors in the frontline treatment of hl
-
1:48
immune checkpoint inhibitors for cutaneous t-cell lymphoma
-
2:29
the importance of pd1 blockade in the treatment of classical hl
-
1:11
distinkt trial analysis: efficacy and safety of imc-001 for r/r enktl
-
4:00
cancer immunotherapy - pd-1 and pd-l1
-
2:10
proclipi: registry & establishment of a prognostic index for mf and ss
-
5:33
cancer immune checkpoint inhibitors
-
12:12
immune checkpoint proteins
-
3:29
pd-l1/pd-1 pathway: a security checkpoint
-
1:17
checkpoint inhibitors for cutaneous lymphoma: the way of the future?
-
1:51
refract: standard chemoimmunotherapy versus novel agents in r/r follicular lymphoma
-
1:29
the evolving treatment landscape of r/r fl & the importance of individualizing treatment approaches
-
18:58
pd-l1 testing by immunohistochemistry
-
1:52
results of phase i study of mcl-1 inhibition with azd5991 in r/r hematologic malignancies
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
1:22
phase i study of ioa-244 in follicular lymphoma
-
2:53
considering the sequencing of covalent and non-covalent btk inhibitors in cll
-
2:22
epcore cll-1: phase i trial of epcoritamab in r/r cll
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents